{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-045012","form_type":"8-K","ticker":"FBIO","cik":"0001429260","company_name":"Fortress Biotech, Inc.","filed_at":"2023-04-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.833607+00:00","generated_at":"2026-06-17T02:34:07.667244+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Fortress Biotech shareholders approve issuance of rights and Contingent Subsidiary Securities","bullets":["Special meeting held April 10, 2023; quorum of 60,355,029 shares (53.2%).","Proposal to satisfy Nasdaq Listing Rule 5635(c) approved: 50,498,193 for, 9,743,984 against, 112,852 abstentions.","No broker non-votes on the issuance proposal.","Approval allows issuance of rights and contingent securities in connection with prior financing arrangements.","Vote was required under Nasdaq rules due to potential dilution exceeding 20% of common stock."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-045012","json":"https://secwatch.observer/filing/0001104659-23-045012.json","markdown":"https://secwatch.observer/filing/0001104659-23-045012.md","text":"https://secwatch.observer/filing/0001104659-23-045012.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1429260/000110465923045012/0001104659-23-045012-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1429260/000110465923045012/tm2312804d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T02:34:07.667244+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"49bc7889d9b5dd3883fa2a9de974f6bdebce5de0","claim":"Fortress Biotech, Inc. shareholders approved Approval of the issuance of the rights and Contingent Subsidiary Securities in order to satisfy the requirements of Nasdaq Listing Rule 5635(c) at the 2023-04-10 meeting.","evidence_excerpt":"Total Votes For Total Votes Against Abstentions Broker Non-Votes 50,498,193 9,743,984 112,852 0","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1429260/000110465923045012/0001104659-23-045012-index.htm","confidence":0.95,"family_label":"Shareholder Votes","details":[{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-04-10"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}